Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LB1148 for return of bowel function in bowel resection
NCT05470387Phase 3Terminated
- Sponsor
- Palisade Bio
- Start
- Jun 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of LB1148 in postoperative ileus (POI), sponsored by Palisade Bio. Started Jun 2022; status: terminated.
02
Drugs
LB1148
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT05470387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05470387.